Director - Real World Data (RWD) Strategy - CMH

Role: Lead enterprise strategy for Real World Data (RWD) in Lilly's Cardiometabolic Health (CMH) portfolio, driving innovation, evaluation, and governance of RWD assets throughout the product lifecycle. Responsibilities: develop RWD strategic vision; create frameworks for measuring RWD value; oversee data landscaping, acquisition, and evaluation; advance integration of emerging technologies like AI; ensure compliance with privacy and data standards; foster external partnerships; and promote RWD literacy across teams. Requirements: advanced degree (PharmD, MD, PhD, MS, MPH); 5+ years hands-on experience with diverse RWD sources (claims, EMR, registry, multi-modal, genomic, imaging); strong analytical (e.g., SAS, R, Python); proven ability to influence decision-making; knowledge of drug development, regulatory use of RWE, and global data strategies. HighValue: leadership in RWD strategy, innovation, and data governance; extensive biopharma data experience; cross-functional influence; familiarity with AI, federated data, and health equity considerations. WorkSetup: not specified; travel may be necessary.